| Reference |
| Originated By | Issue Date | Status |
| CEM/CMO/2021/017 |
Casirivimab and imdevimab for patients hospitalised due to COVID-19
| CMO Messaging |
17-Sep-2021
| Issued |
| SDA/2021/011 |
Becton Dickinson blood specimen collection - supply disruption (update)
| DHSC & NHS England and Improvement: Supply disruption alert |
16-Sep-2021
| Issued |
| CEM/CMO/2021/016 |
Interleukin-6 inhibitors (tocilzumab or sarilumab) for patients hospitalised due to COVID-19
| CMO Messaging |
12-Sep-2021
| Issued |
| CEM/CMO/2021/015 |
COVID-19 Therapeutic Alert: Continuous positive airway pressure (CPAP) in patients hospitalised due ...
| CMO Messaging |
02-Sep-2021
| Issued |
| SDA/2021/010 |
Becton Dickinson blood specimen collection - supply disruption
| DHSC & NHS England and Improvement: Supply disruption alert |
26-Aug-2021
| Issued |
| NatPSA/2021/009/NHSPS |
Infection risk when using FFP3 respirators with valves or Powered Air Purifying Respirators (PAPRs) ...
| National Patient Safety Alert - NHS England & NHS Improvement |
25-Aug-2021
| Issued |
| NatPSA/2021/008/NHSPS |
Elimination of bottles of liquefied phenol 80%
| National Patient Safety Alert - NHS England & NHS Improvement |
25-Aug-2021
| Issued |
| NatPSA/2021/007/PHE |
Potent synthetic opioids implicated in increase in drug overdoses
| National Patient Safety Alert - Public Health England |
18-Aug-2021
| Issued |
| SDA/2021/009 |
Glipizide (Minodiab) 5mg tablets - Supply disruption
| DHSC & NHS England and Improvement: Supply disruption alert |
02-Aug-2021
| Issued |
| SDA/2021/008 |
Tinzaparin sodium (10,000 IU/ml) 3,500 units in 0.35ml and 4,500 units in 0.45ml pre-filled syringes ...
| DHSC & NHS England and Improvement: Supply disruption alert |
29-Jul-2021
| Issued |
|